News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
309,064 Results
Type
Article (15404)
Company Profile (283)
Press Release (293377)
Multimedia
Podcasts (48)
Webinars (7)
Section
Business (91648)
Career Advice (161)
Deals (16179)
Drug Delivery (35)
Drug Development (53711)
Employer Resources (31)
FDA (6860)
Job Trends (5612)
News (165284)
Policy (12332)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioMidwest Digital (4)
2024 Bio NC Digital (4)
2024 Biotech Bay Standard (11)
2024 Biotech Beach Digital (5)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (7)
2024 Genetown Standard (6)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (3)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (3)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (964)
Accelerated approval (2)
Adcomms (12)
Allergies (55)
Alliances (26115)
ALS (64)
Alzheimer's disease (895)
Antibody-drug conjugate (ADC) (90)
Approvals (6896)
Artificial intelligence (125)
Autoimmune disease (17)
Automation (5)
Bankruptcy (111)
Best Places to Work (4871)
BIOSECURE Act (5)
Biosimilars (51)
Biotechnology (235)
Bladder cancer (49)
Brain cancer (20)
Breast cancer (161)
Cancer (1436)
Cardiovascular disease (117)
Career advice (141)
Career pathing (2)
CAR-T (110)
Cell therapy (320)
Cervical cancer (8)
Clinical research (43804)
Collaboration (546)
Compensation (259)
Complete response letters (13)
COVID-19 (1119)
CRISPR (39)
C-suite (161)
Cystic fibrosis (76)
Data (1482)
Denatured (11)
Depression (30)
Diabetes (135)
Diagnostics (1741)
Digital health (4)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (84)
Drug pricing (28)
Drug shortages (3)
Duchenne muscular dystrophy (89)
Earnings (34193)
Editorial (18)
Employer branding (4)
Employer resources (29)
Events (52320)
Executive appointments (462)
FDA (7590)
Featured Employer (31)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (507)
Gene editing (93)
Generative AI (10)
Gene therapy (252)
GLP-1 (387)
Government (1202)
Grass and pollen (3)
Guidances (22)
Healthcare (7145)
Huntington's disease (22)
IgA nephropathy (23)
Immunology and inflammation (89)
Indications (19)
Infectious disease (1189)
Inflammatory bowel disease (116)
Inflation Reduction Act (8)
Influenza (24)
Intellectual property (68)
Interviews (17)
IPO (8111)
IRA (11)
Job creations (1039)
Job search strategy (135)
Kidney cancer (6)
Labor market (5)
Layoffs (211)
Leadership (3)
Legal (2140)
Liver cancer (40)
Lung cancer (205)
Lymphoma (93)
Machine learning (2)
Management (7)
Manufacturing (141)
MASH (53)
Medical device (3526)
Medtech (3528)
Mergers & acquisitions (8434)
Metabolic disorders (390)
Multiple sclerosis (54)
NASH (13)
Neurodegenerative disease (65)
Neuropsychiatric disorders (23)
Neuroscience (1296)
NextGen: Class of 2025 (2138)
Non-profit (894)
Northern California (1667)
Now hiring (22)
Obesity (197)
Opinion (102)
Ovarian cancer (61)
Pain (44)
Pancreatic cancer (60)
Parkinson's disease (122)
Partnered (9)
Patents (129)
Patient recruitment (70)
Peanut (35)
People (28192)
Pharmaceutical (48)
Pharmacy benefit managers (5)
Phase I (15131)
Phase II (20180)
Phase III (13198)
Pipeline (814)
Policy (43)
Postmarket research (992)
Preclinical (6320)
Press Release (32)
Prostate cancer (60)
Psychedelics (35)
Radiopharmaceuticals (220)
Rare diseases (292)
Real estate (1873)
Recruiting (12)
Regulatory (10121)
Reports (18)
Research institute (982)
Resumes & cover letters (17)
Rett syndrome (4)
RNA editing (4)
RSV (10)
Schizophrenia (58)
Series A (98)
Series B (63)
Service/supplier (1)
Sickle cell disease (41)
Southern California (1470)
Special edition (11)
Spinal muscular atrophy (117)
Sponsored (11)
Startups (2178)
State (1)
Stomach cancer (5)
Supply chain (21)
Tariffs (5)
The Weekly (36)
United States (13142)
Vaccines (223)
Venture capitalists (31)
Weight loss (108)
Women's health (15)
Worklife (2)
Date
Today (14)
Last 7 days (280)
Last 30 days (1503)
Last 365 days (20738)
2025 (5784)
2024 (21889)
2023 (23988)
2022 (30278)
2021 (31175)
2020 (26638)
2019 (18410)
2018 (13484)
2017 (15658)
2016 (13766)
2015 (16838)
2014 (12489)
2013 (9344)
2012 (9561)
2011 (9737)
2010 (9327)
Location
Africa (197)
Alabama (41)
Alaska (2)
Arizona (59)
Arkansas (5)
Asia (30115)
Australia (4380)
California (3787)
Canada (1191)
China (383)
Colorado (142)
Connecticut (149)
Delaware (94)
Europe (44614)
Florida (451)
Georgia (117)
Idaho (16)
Illinois (226)
India (14)
Indiana (91)
Iowa (1)
Japan (119)
Kansas (65)
Kentucky (5)
Louisiana (3)
Maine (13)
Maryland (494)
Massachusetts (3030)
Michigan (71)
Minnesota (165)
Mississippi (1)
Missouri (26)
Montana (14)
Nebraska (4)
Nevada (18)
New Hampshire (14)
New Jersey (1000)
New Mexico (12)
New York (1039)
North Carolina (552)
North Dakota (4)
Northern California (1667)
Ohio (109)
Oklahoma (9)
Oregon (22)
Pennsylvania (715)
Puerto Rico (5)
Rhode Island (17)
South America (274)
South Carolina (4)
Southern California (1470)
Tennessee (25)
Texas (427)
Utah (59)
Virginia (74)
Washington D.C. (31)
Washington State (339)
Wisconsin (18)
309,064 Results for "tessa therapeutics pte ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Newly-formed Archerfish Precision Diagnostics Pte Ltd: Ushers a New Era in Advanced Diagnostics
March 6, 2025
·
5 min read
Press Releases
Tenpoint Therapeutics Ltd. to Participate in Upcoming Investor Conferences in April
April 1, 2025
·
2 min read
Press Releases
ATED Therapeutics, Ltd.: New Rapid, Simple Blood Test for Parkinson’s Disease Developed
April 14, 2025
·
2 min read
Press Releases
Tenpoint Therapeutics Ltd. Appoints Carol Kearney as Chief Commercial Officer
March 11, 2025
·
3 min read
Press Releases
Tenpoint Therapeutics Ltd. Submits New Drug Application to U.S. FDA for BRIMOCHOL™ PF for the Treatment of Presbyopia
April 8, 2025
·
5 min read
Bio NC
BioSkryb Genomics Partners with Research Instruments Pte Ltd to Bring Industry Leading Single-Cell Technologies to Singapore and Southeast Asia
BioSkryb Genomics announced a partnership with Research Instruments Pte Ltd, a premier distributor for genomic and life science research products in Southeast Asia, to distribute BioSkryb’s ResolveDNA® and ResolveOME™ single cell amplification tools throughout Singapore and Southeast Asia.
August 29, 2023
·
4 min read
Biotech Bay
ValGenesis and Radiant Digital PTE Ltd. Partner to Enable Digital Transformation Across Life Sciences in Singapore
ValGenesis, Inc., the market leader in enterprise validation lifecycle management systems, and Radiant Digital PTE Ltd. a provider of digital transformation delivery services to commercial and government clients, have partnered to facilitate the digital transformation of life sciences companies in Singapore.
June 20, 2023
·
3 min read
Press Releases
Relmada Therapeutics Licenses Phase 2 Bladder Cancer Candidate, NDV-01, from Trigone Pharma, Ltd.
March 26, 2025
·
10 min read
Tessa Therapeutics Enters into Cooperative Research and Development Agreement (CRADA) with the U.S. National Cancer Institute
Tessa Therapeutics Ltd. announced entry into a Cooperative Research and Development Agreement with the U.S. National Cancer Institute, part of the National Institutes of Health, to investigate TT11X, Tessa’s allogeneic “off-the-shelf” CD30.CAR-modified Epstein-Barr virus-specific T-cell therapy, in multiple subtypes of non-Hodgkin lymphoma.
March 8, 2023
·
5 min read
Tessa Therapeutics’ ‘Off-the-Shelf’ CAR-T Therapy Shows Promising Results in Early-Stage Study of Hodgkin Lymphoma
Tessa Therapeutics Ltd., a clinical-stage cell therapy company developing next-generation cancer treatments for hematological malignancies and solid tumors, announced promising safety and efficacy data from a study of its off-the-shelf CD30.CAR EBVST therapy in patients with relapsed or refractory Hodgkin lymphoma.
June 15, 2023
·
6 min read
1 of 30,907
Next
